Daisuke Tokita

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Journal: BMJ open

Published: August 26, 2026

AI in clinical trials: Current status, challenges, and future directions for emergency infectious disease clinical trials -Insights from the 2025 iCROWN Symposium.

AI in clinical trials: Current status, challenges, and future directions for emergency infectious disease clinical trials -Insights from the 2025 iCROWN Symposium.

Journal: Global health & medicine

Published: February 12, 2026

Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Journal: Molecular cancer research : MCR

Published: August 27, 2025

Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia.

Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia.

Journal: Global health & medicine

Published: February 28, 2025

The Academic Research Organization Alliance for Southeast and East Asia (ARISE) in the new era: An international trials network towards pandemic preparedness.

The Academic Research Organization Alliance for Southeast and East Asia (ARISE) in the new era: An international trials network towards pandemic preparedness.

Journal: GHM open

Published: January 14, 2025

LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 25, 2024

Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2.

Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2.

Journal: Scientific reports

Published: July 10, 2024

Unveiling Spatial Immune Cell Profile in Kidney Allograft Rejections Using 36-plex Immunofluorescence Imaging.

Unveiling Spatial Immune Cell Profile in Kidney Allograft Rejections Using 36-plex Immunofluorescence Imaging.

Journal: Transplantation

Published: June 24, 2024

Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: April 12, 2024

How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic.

How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic.

Journal: Clinical pharmacology and therapeutics

Published: October 23, 2023

Efficacy and Safety of Pre-Exposure Prophylaxis to Control HIV and Sexually Transmitted Infection Among Men Who Have Sex With Men: Protocol for a Single-Arm Interventional Study.

Efficacy and Safety of Pre-Exposure Prophylaxis to Control HIV and Sexually Transmitted Infection Among Men Who Have Sex With Men: Protocol for a Single-Arm Interventional Study.

Journal: JMIR research protocols

Published: August 01, 2023

Clinical trial experience in Japan and future issues in developing drugs to treat COVID-19.

Clinical trial experience in Japan and future issues in developing drugs to treat COVID-19.

Journal: Global health & medicine

Published: March 20, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026